-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GNDTlmb4+pnfKKWe8/6CgIhd8yx8+vjeVb7k6BU6y4DOAr8RzJnnkCCligbFsip1 Ayae+g30TB5o0HMYTuMFIw== 0000732485-03-000027.txt : 20030709 0000732485-03-000027.hdr.sgml : 20030709 20030709102113 ACCESSION NUMBER: 0000732485-03-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030630 FILED AS OF DATE: 20030709 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIRTH PETER CENTRAL INDEX KEY: 0001021041 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 03779328 BUSINESS ADDRESS: STREET 1: C/O GENZYME CORP STREET 2: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wir49.xml X0101 4 2003-06-30 0 0000732485 GENZYME CORP GENZ 0001021041 WIRTH PETER 0 1 0 0 Executive Vice President Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 29788 0 D 0 D Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 1 0 D 0 I By 401(k) Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 3030 0 D 0 I By Keogh Plan Genzyme General common stock (GENZ) 2003-06-30 4 J 0 1463 0 A 41651 D Genzyme General common stock (GENZ) 2003-06-30 4 J 0 9 0 A 41660 D Genzyme General common stock (GENZ) 2003-06-30 4 J 0 148 0 A 148 I By Keogh Plan Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 171 0 D 0 D Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 6 0 D 0 I By 401(k) Biosurgery ISO stock option (right to buy) 36.55 2003-06-30 4 J 0 1709 0 D 1996-05-16 2006-05-16 Genzyme Biosurgery common stock (GZBX) 1709 0 D Biosurgery ISO stock option (right to buy) 29.83 2003-06-30 4 J 0 4190 0 D 1996-10-01 2006-10-01 Genzyme Biosurgery common stock (GZBX) 4190 0 D Biosurgery NQ stock option (right to buy) 29.46 2003-06-30 4 J 0 4559 0 D 1997-10-16 2007-10-16 Genzyme Biosurgery common stock (GZBX) 4559 0 D Biosurgery NQ stock option (right to buy) 19.39 2003-06-30 4 J 0 2279 0 D 1998-05-28 2008-05-28 Genzyme Biosurgery common stock (GZBX) 2279 0 D Biosurgery NQ stock option (right to buy) 23.12 2003-06-30 4 J 0 12347 0 D 2001-01-25 2009-01-25 Genzyme Biosurgery common stock (GZBX) 12347 0 D Biosurgery NQ stock option (right to buy) 11.04 2003-06-30 4 J 0 5817 0 D 1999-08-26 2009-08-26 Genzyme Biosurgery common stock (GZBX) 5817 0 D Biosurgery NQ stock option (right to buy) 6.69 2003-06-30 4 J 0 10520 0 D 2001-07-17 2011-02-09 Genzyme Biosurgery common stock (GZBX) 10520 0 D Biosurgery NQ stock option (right to buy) 6.26 2003-06-30 4 J 0 13000 0 D 2001-05-31 2011-05-31 Genzyme Biosurgery common stock (GZBX) 13000 0 D Biosurgery NQ stock option (right to buy) 4.24 2003-06-30 4 J 0 29700 0 D 2002-05-30 2012-05-30 Genzyme Biosurgery common stock (GZBX) 29700 0 D Genzyme General ISO stock option (right to buy) 739.13 2003-06-30 4 J 0 84 0 A 1996-06-16 2006-05-16 Genzyme General common stock (GENZ) 84 84 D Genzyme General ISO stock option (right to buy) 603.24 2003-06-30 4 J 0 207 0 A 1996-10-01 2006-10-01 Genzyme General common stock (GENZ) 207 207 D Genzyme General NQ stock option (right to buy) 595.76 2003-06-30 4 J 0 225 0 A 1997-10-16 2007-10-16 Genzyme General common stock (GENZ) 225 225 D Genzyme General NQ stock option (right to buy) 124.69 2003-06-30 4 J 0 1403 0 A 1997-10-16 2007-10-16 Genzyme General common stock (GENZ) 1403 1403 D Genzyme General NQ stock option (right to buy) 392.12 2003-06-30 4 J 0 112 0 A 1998-05-28 2008-05-28 Genzyme General common stock (GENZ) 112 112 D Genzyme General NQ stock option (right to buy) 124.69 2003-06-30 4 J 0 763 0 A 1998-05-28 2008-05-28 Genzyme General common stock (GENZ) 763 763 D Genzyme General NQ stock option (right to buy) 467.55 2003-06-30 4 J 0 610 0 A 2001-01-25 2009-01-25 Genzyme General common stock (GENZ) 610 610 D Genzyme General NQ stock option (right to buy) 95.84 2003-06-30 4 J 0 2067 0 A 2001-01-25 2009-01-25 Genzyme General common stock (GENZ) 2067 2067 D Genzyme General NQ stock option (right to buy) 223.26 2003-06-30 4 J 0 287 0 A 1999-08-26 2009-08-26 Genzyme General common stock (GENZ) 287 287 D Genzyme General NQ stock option (right to buy) 226.76 2003-06-30 4 J 0 1208 0 A 2000-05-25 2010-05-25 Genzyme General common stock (GENZ) 1208 1208 D Genzyme General NQ stock option (right to buy) 135.29 2003-06-30 4 J 0 520 0 A 2001-07-17 2011-02-09 Genzyme General common stock (GENZ) 520 520 D Genzyme General NQ stock option (right to buy) 126.60 2003-06-30 4 J 0 642 0 A 2001-05-31 2011-05-31 Genzyme General common stock (GENZ) 642 642 D Genzyme General NQ stock option (right to buy) 274.32 2003-06-30 4 J 0 1571 0 A 2001-05-31 2011-05-31 Genzyme General common stock (GENZ) 1571 1571 D Genzyme General NQ stock option (right to buy) 85.75 2003-06-30 4 J 0 1468 0 A 2002-05-30 2012-05-30 Genzyme General common stock (GENZ) 1468 1468 D Genzyme General NQ stock option (right to buy) 41.51 2003-06-30 4 J 0 2245 0 A 2002-05-30 2012-05-30 Genzyme General common stock (GENZ) 2245 2245 D Molecular Oncology NQ stock option (right to buy) 7.00 2003-06-30 4 J 0 25000 0 D 1997-10-16 2007-10-16 Genzyme Molecular Oncology common stock (GZMO) 25000 0 D Molecular Oncology NQ stock option (right to buy) 7.00 2003-06-30 4 J 0 13602 0 D 1998-05-28 2008-05-28 Genzyme Molecular Oncology common stock (GZMO) 13602 0 D Molecular Oncology NQ stock option (right to buy) 5.38 2003-06-30 4 J 0 36835 0 D 2001-01-25 2009-01-25 Genzyme Molecular Oncology common stock (GZMO) 36835 0 D Molecular Oncology NQ stock option (right to buy) 12.73 2003-06-30 4 J 0 21525 0 D 2000-05-25 2010-05-25 Genzyme Molecular Oncology common stock (GZMO) 21525 0 D Molecular Oncology NQ stock option (right to buy) 15.40 2003-06-30 4 J 0 28000 0 D 2001-05-31 2011-05-31 Genzyme Molecular Oncology common stock (GZMO) 28000 0 D Molecular Oncology NQ stock option (right to buy) 2.33 2003-06-30 4 J 0 40000 0 D 2002-05-30 2012-05-30 Genzyme Molecular Oncology common stock (GZMO) 40000 0 D On June 30, 2003 all outstanding shares of Genzyme Biosurgery and Genzyme Molecular stock were exchanged for shares of Genzyme General Stock. Genzyme Biosurgery shareholders received .04914 of a share of Genzyme General stock for each Biosurgery share and Genzyme Molecular Oncology shareholders received .05653 of a share of Genzyme General stock for each Molecular Oncology share. On June 30, 2003 in relation to the elimination of Genzyme's tracking stock structure, all stock options of Genzyme Biosurgery and Genzyme Molecular were exchanged for stock options of Genzyme General. The exchange ratio was based on the closing prices of all three stocks on 6/30/03. Genzyme Biosurgery options were exchanged at a rate of .04945 and Genzyme Molecular Oncology options were exchanged at a rate of .05614. Options vest in 20% annual increments beginning 5/16/96. Options vest in 20% annual increments beginning 10/1/96 Options vest 20% on October 16, 1997 and in 20% annual increments beginning May 16, 1998. Options vest in 20% annual increments beginning on the original date of grant. Options were granted with an exercise price 100% above fair market value, and vest in 1/3 increments on each of Janary 25, 2001, 2002 and 2003. Options vest 20% on August 26, 1999 and in 20% annual increments beginning May 26, 2000. Options vest in 25% annual increments on July 17, 2001, 2002, 2003 and 2004. By: Susan P. Cogswell, Attorney-in-Fact 2003-07-02 -----END PRIVACY-ENHANCED MESSAGE-----